Request Appointment
353 East 68th StreetNew York, NY 10065
Overview of Dr. Donahue
Dr. Timothy Donahue is an urologist in New York, NY and is affiliated with multiple hospitals in the area, including Memorial Sloan Kettering Cancer Center and Memorial Hospital for Cancer and allied Diseases. He received his medical degree from Boston University School of Medicine and has been in practice 22 years. He is one of 84 doctors at Memorial Sloan Kettering Cancer Center and one of 16 doctors at Memorial Hospital for Cancer and allied Diseases who specialize in Urology. He has more than 60 publications and over 500 citings.
Education & Training
Memorial Sloan Kettering Cancer CenterFellowship, Urologic Surgical Oncology, 2012 - 2014
National Capital ConsortiumResidency, Urology, 1997 - 2001- National Capital ConsortiumInternship, Transitional Year, 1995 - 1996
Boston University School of MedicineClass of 1995
Certifications & Licensure
NY State Medical License 2012 - 2025
MD State Medical License 1997 - 2016
American Board of Urology Urology
Clinical Trials
- Fluorescent Imaging of Nerves with Illuminare-1 During Surgery Start of enrollment: 2021 Oct 04
Publications & Presentations
PubMed
- Re-analysis of intravesical gemcitabine in the era of Bacillus Calmette-Guérin (BCG)-unresponsive non-muscle-invasive bladder cancer.Manuel R De Jesus Escano, Emily A Vertosick, Neeta D'Souza, Nicole Benfante, Andrew T Lenis
Urologic Oncology. 2025-05-24 - 1 citationsClinical Outcomes, Genomic Heterogeneity, and Therapeutic Considerations Across Histologic Subtypes of Urothelial Carcinoma.Carissa E Chu, Ziyu Chen, Karissa Whiting, Irina Ostrovnaya, Andrew T Lenis
European Urology. 2025-04-26 - 1 citationsPerioperative Complications and Omission of Ureteral Stents During Robot-Assisted Radical Cystectomy With Intracorporeal Ileal Conduit.Jacob E Tallman, Emily A Vertosick, Syed M Alam, Fady J Baky, S Machele Donat
The Journal of Urology. 2025-04-01
Press Mentions
Could Common Blood Pressure Meds Help Curb Pancreatic Cancer?February 25th, 2022- Combination Therapy Suppresses Pancreatic Tumour Growth: StudyFebruary 25th, 2021
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
